Contact Us

PW Case Review Form
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

   * Please describe your case:

What injury have you suffered?

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


GlaxoSmithKline Recalls Epilepsy Drug

Apr 8, 2005 | AP

GlaxoSmithKline is recalling about 100,000 starter kits of Lamictal, a drug used to treat epilepsy and bipolar disorder.

The pharmaceutical giant said the wrong dosage was found in two of the kits.

The kits are designed so that patients gradually increase their dosage of the drug over several weeks. A company spokeswoman said the errant kits supplied a white 25 milligram pill rather than a pink 100 milligram pill for the fifth week.

A Glaxo spokeswoman said there's no problem with the tablets or with the bottles.

About 150,000 epileptics use the drug to ward off seizures and another 100,000 people use it to treat bipolar disorder.

GlaxoSmithKline manufactures the drug at its plant in Zebulon, N.C.


Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo